The University of Chicago Header Logo

Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival.

Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecol Oncol. 1996 Oct; 63(1):28-33.

View in: PubMed